Influence of various factors on the efficiency of trabeculectomy in pediatric patients with congenital glaucoma

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

AIM: The study aimed to analyze the influence of various factors on the efficiency of trabeculectomy in pediatric patients with congenital glaucoma.

MATERIAL AND METHODS: The results of 945 trabeculectomies, including those with various modifications and the use of drains, in pediatric patients with congenital glaucoma were analyzed in the Department of Pediatric Eye Pathology of the Helmholtz National Medical Research Center for Eye Diseases for 1997–2023.

RESULTS: The efficiency of trabeculectomy in pediatric patients with congenital glaucoma was 91.9%–98.5% in the immediate period (up to 6 months) after surgery, 75.5%–86.5% in the long term (after 5 years), and 34.2%–42.1% with repeated surgeries (up to 3–4 surgeries) during follow-up up to 10 years, which is comparable with literature data.

CONCLUSION: The main factors that influence the efficiency of trabeculectomy in pediatric patients with congenital glaucoma include age at the time of detection and surgical treatment of congenital glaucoma, their somatic health, glaucoma stage, and severity of destructive changes in the eye, particularly the congenital ones, presence of repeated surgeries, erroneous choice of the trabecular site subject to excision during surgery, injury rate of trabeculectomy (quality of incision of the conjunctiva, sclera, injury rate of vessel coagulation during surgery, and skill of the surgeon), presence of intra- and postoperative complications, untimely detection and YAG laser elimination of the internal fistula fusion after trabeculectomy, and inadequate management of the postoperative period.

About the authors

Nataliya N. Arestova

Helmholtz National Medical Research Center of Eye Diseases; N.A. Semashko Scientific and Educational Institute of Clinical Medicine of the Russian University of Medicine

Author for correspondence.
Email: arestovann@gmail.com
ORCID iD: 0000-0002-8938-2943
SPIN-code: 4875-6288

MD, Dr. Sci. (Med.)

Russian Federation, 14/19, Sadovaya Chernogryazskaya St., 105062 Moscow; Moscow

Dmitry O. Arestov

Helmholtz National Medical Research Center of Eye Diseases

Email: arestovann@gmail.com
SPIN-code: 7396-8551

MD, Cand. Sci. (Med.)

Russian Federation, 14/19, Sadovaya Chernogryazskaya St., 105062 Moscow

Anna Yu. Panova

Helmholtz National Medical Research Center of Eye Diseases

Email: annie_panova18@mail.ru
ORCID iD: 0000-0003-2103-1570
SPIN-code: 9930-4813

MD, Cand. Sci. (Med.)

Russian Federation, 14/19, Sadovaya Chernogryazskaya St., 105062 Moscow

References

  1. Gilbert CE, Rahi JS, Quinn GE. Visual impairment and blindness in children. Johnson GJ, Minassian DC, Weale RA, West SK, editors. The Epidemiology of Eye Disease. 3nd ed. London: Edward Arnold Ltd; 2003. P. 260–285
  2. Biglan AW. Glaucoma in children: Are we making progress? J Am Assoc Pediatr Ophthalmol Strabismus. 2006;10(7):21. doi: 10.1016/j. jaapos.2005.10.001
  3. Fung DS, Roensch MA, Kooner KS, et al. Epidemiology and characteristics of childhood glaucoma: results from the Dallas Glaucoma Registry. Clin Ophthalmol. 2013;7:1739–1746. doi: 10.2147/opth.s45480
  4. Badawi AH, Al-Muhaylib AA, Al Owaifeer AM, et al. Primary congenital glaucoma: An updated review. Saudi J Ophthalmol. 2019;33(4):382–388. doi: 10.1016/j.sjopt.2019.10.002
  5. Papadopoulos M, Edmunds B, Fenerty C, Khaw PT. Childhood glaucoma surgery in the 21st century. Eye (Lond). 2014;28(8):931–943. doi: 10.1038/eye.2014.140
  6. Mocan MC, Mehta AA, Aref AA. Update in Genetics and Surgical Management of Primary Congenital Glaucoma. Turk J Ophthalmol. 2019;49(6):347–355. doi: 10.4274/tjo.galenos.2019.28828
  7. Katargina LA, Sorokin AA, Arestova NN, et al. The spectrum of clinical manifestations of primary congenital glaucoma according to the data of referrals to the National Medical Research Center of Eye Diseases. Russian Ophthalmological Journal. 2022;15(3):26–33. (in Russ.) doi: 10.21516/2072-0076-2022-15-3-26-33
  8. Sidorov EG, Mirzayants MG. Congenital glaucoma and its treatment. Moscow: Medicina; 1991. 208 p. (in Russ.)
  9. Kulkarni SV, Damji KF, Fournier AV, et al. Endoscopic goniotomy: early clinical experience in congenital glaucoma. J Glaucoma. 2010;19(4):264–269. doi: 10.1097/IJG.0b013e3181b21ede
  10. Girkin CA, Marchase N, Cogen MS. Circumferential trabeculotomy with an illuminated microcatheter in congenital glaucomas. J. Glaucoma. 2012;21(3):160–163. doi: 10.1097/IJG.0b013e31822af350
  11. Chen TC, Chen PP, Francis BA, et al. Pediatric glaucoma surgery: a report by the American Academy of Ophthalmology. Ophthalmology. 2014;121(11):2107–2115. doi: 10.1016/j.ophtha.2014.05.010
  12. Dao JB, Sarkisian SR Jr, Freedman SF. Illuminated microcatheter-facilitated 360-degree trabeculotomy for refractory aphakic and juvenile open-angle glaucoma. J Glaucoma. 2014;23(7):449–454. doi: 10.1097/IJG.0b013e31829484df
  13. Khan AO. A Surgical Approach to Pediatric Glaucoma. Open Ophthalmol J. 2015;9:104–112. doi: 10.2174/1874364101509010104
  14. Scuderi G, Iacovello D, Pranno F, et al. Pediatric Glaucoma: A Literature’s Review and Analysis of Surgical Results. Biomed Res Int. 2015;2015:393670. doi: 10.1155/2015/393670
  15. Temkar S, Gupta S, Sihota R, et al. Illuminated microcatheter circumferential trabeculotomy versus combined trabeculotomy-trabeculectomy for primary congenital glaucoma: a randomized controlled trial. Am J Ophthalmol. 2015;159(3):490–497. doi: 10.1016/j.ajo.2014.12.001
  16. Huang JL, Huang JJ, Zhong YM, et al. Surgical outcomes of trabeculotomy in newborns with primary congenital glaucoma. Chin Med J. 2016;129:2178–2183. doi: 10.4103/0366-6999.189925
  17. Grehn F. New horizons in congenital glaucoma surgery. Acta Ophthalmol. 2018;96(1):7–8. doi: 10.1111/aos.13589
  18. Dureau P, Dollfus H, Cassegrain C, Dufier JL. Long-term results of trabeculectomy for congenital glaucoma. J Pediatr Ophthalmol Strabismus. 1998;35(4):198–202. doi: 10.3928/0191-3913-19980701-05
  19. Gagrani M, Garg I, Ghate D. Surgical interventions for primary congenital glaucoma. Cochrane Database Syst Rev. 2020;8(8):CD008213. doi: 10.1002/14651858.CD008213.pub3
  20. Lee YJ, Ha A, Kang D, et al. Comparative efficacies of 13 surgical interventions for primary congenital glaucoma in children: a network meta-analysis of randomized clinical trials. Int J Surg. 2023;109(4):953–962. doi: 10.1097/JS9.0000000000000283
  21. Sadovnikova NN, Prisich NV, Brzhesky VV, et al. Drainage devices in glaucoma surgery in children. Modern technologies in ophthalmology. 2019;(3):170–174 (in Russ.) doi: 10.25276/2312-4911-2019-3-170-174
  22. Chen A, Yu F, Law SK, et al. Valved glaucoma drainage devices in pediatric glaucoma. Retrospective long-term outcomes. JAMA Ophthalmol. 2015;133(9):1030–1035. doi: 10.1001/jamaophthalmol.2015.1856
  23. Pakravan M, Esfandiari H, Yazdani S, et al. Clinical outcomes of Ahmed glaucoma valve implantation in pediatric glaucoma. Eur J Ophthalmol. 2019;29(1):44–51. doi: 10.1177/1120672118761332
  24. Al-Hazmi A, Awad A, Zwaan J, et al. Correlation between surgical success rate and severity of congenital glaucoma. Br J Ophthalmol. 2005;89:449–453. doi: 10.1136/bjo.2004.047761
  25. Khaw PT. What is the best primary surgical treatment for infantile glauсoma. Br J Ophthalmol. 1996;80(6):495–496. doi: 10.1136/ bjo.80.6.495
  26. O’Malley, Schotthoefer E, Yanovitch TL, et al. Aqueous drainage device surgery in refractory pediatric glaucomas: I. Long-term outcomes. J Am Assoc Pediatric Ophthalmol Strabismus. 2008;12:33–39. doi: 10.1016/j.jaapos.2007.07.002
  27. Sidoti PA, Belmonte SJ, Liebmann JM, Ritch R. Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. Ophthalmology. 2000;104:422–429. doi: 10.1016/s0161-6420(99)00130-x
  28. Giampani J Jr, Borges-Giampani AS, Carani JC, et al. Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up. Clinics (Sao Paulo). 2008;63(4):421–426. doi: 10.1590/s1807-59322008000400002
  29. Lazareva AK, Kuleshova ON, Aidagulova SV, et al. Features of childhood glaucoma: review of the literature. Nacional Journal Glaukoma. 2019;18(2):102–112 (in Russ.) doi: 10.25700/NJG.2019.02.11
  30. Sadovnikova NN, Brzhesky VV, Zertsalova MA, et al. The structure of “childhood” glaucoma – the results of a 20-year observation. Nacional Journal Glaukoma. 2023; 22(2):71–80 (in Russ.) doi: 10.53432/2078-4104-2023-22-2-71-80
  31. Elder MJ. Congenital glaucoma in the West Bank and Gaza Strip. Br J Ophthalmology. 1993;77(7):413–416. doi: 10.1136/bjo.77.7.413
  32. Plásilová M, Feráková E, Kádasi L, et al. Linkage of autosomal recessive primary congenital glaucoma to the GLC3A locus in Roms (Gypsies) from Slovakia. Hum Hered. 1998;48(1):30–33. doi: 10.1159/000022778
  33. Dietlein TS, Jacobi PC, Krieglstein GK. Prognosis of primary ab externo surgery for primary congenital glaucoma. Br J Ophthalmol. 1999;83(3):317–322. doi: 10.1136/bjo.83.3.317
  34. Bejjani BA, Lewis RA, Tomey KF, et al. Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia. Am J Hum Genet. 1998;62(2):325–333. doi: 10.1086/301725
  35. Reis LM, Reis LM, Tyler RC, et al. Analysis of CYP1B1 in pediatric and adult glaucoma and other ocular phenotypes. Mol Vis. 2016;22:1229–1238.
  36. Lewis CJ, Lewis CJ, Hedberg-Buenz A, et al. Primary congenital and developmental glaucomas. Hum Mol Genet. 2017;26(1):28–36. doi: 10.1093/hmg/ddx205
  37. Mauri L, Uebe S, Sticht H, et al. Expanding the clinical spectrum of COL1A1 mutations in different forms of glaucoma. Orphanet J Rare Dis. 2016;11(1):108. doi: 10.1186/s13023-016-0495-y
  38. Lebedev OI. The concept of excessive scarring of eye tissue after antiglaucomatous surgery. Vestnik ofthalmologii.1993;(1):36–39 (in Russ.) EDN: YNYQGG
  39. Azuara-Blanco A, Katz LJ. Dysfunctional filtering blebs. Surv Ophthalmol. 1998;43(2):93–126. doi: 10.1016/s0039-6257(98)00025-3
  40. Maumenee AK. External filtering operations for glaucoma: the mechanism of function and failure. Tram Am Ophthalmol Soc. 1960;58:319–328.
  41. Balashova LM. Immunohemostatic mechanisms of primary open-angle glaucoma. Vestnik ofthalmologii. 1992;(3):3–5. (in Russ.)
  42. Chang MR, Cheng Q, Lee DA. Basic science and clinical aspects of wound healing in glaucoma filtering surgery. J Ocul Pharmacol Ther. 1998;14(1):75–95. doi: 10.1089/jop.1998.14.75
  43. Daniels JT, Occleston NL, Crowston JG, et al. Understanding and controlling the scarring response: the contribution of histology and microscopy. Microsc Res Tech. 1998;42(5):317–333. doi: 10.1002/(SICI)1097-0029(19980901)42:5<317::AID-JEMT3>3.0.CO;2-M
  44. Kuleshova ON, Nepomnyashchikh GI, Aidagulova SV. Analysis of morphological changes in juxtacanalicular tissue and sclera based on surgical material in primary juvenile and open-angle glaucoma. Fyodorov Journal of Ophthalmic Surgery. 2008;3:12–15. (in Russ.) EDN: NBPPHD
  45. Addicks EM, Quigley HA, Green WR, Robin AL. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol. 1983;101(5):795–798. doi: 10.1001/archopht.1983.01040010795021
  46. Terraciano AJ, Sidoti PA. Management of refractory glaucoma in childhood. Curr Opin Ophthalmol. 2002;13(2):97–102. doi: 10.1097/ 00055735-200204000-00008
  47. Tanimoto SA, Brandt JD. Options in pediatric glaucoma after angle surgery has failed. Curr Opin Ophthalmol. 2006;17(2):132–137. doi: 10.1097/01.icu.0000193091.60185.27
  48. Tung I, Marcus I, Thiamthat W, Freedman SF. Second glaucoma drainage devices in refractory pediatric glaucoma: failure by fibrovascular ingrowth. Am J Ophthalmol. 2014;158(1):113-117. doi: 10.1016/j.ajo.2014.03.017
  49. Dzhaliashvili OA, Ignatiev AN, Zhorzhos H. Possible causes of increased intraocular pressure after trabeculectomy and ways to eliminate it. Vestnik ofthalmologii. 1997;(2):42–44. (In Russ.)
  50. Allingham RR. Congenital glaucoma. In: Allingham RR, Damji KF, Freedman S, Mori SE, Shafranov G, editors. Shields’ Textbook of Glaucoma. 5th edition. Philadelphia: Lippincott Williams & Wilkins; 2005. P. 235–252.
  51. Miller MH, Rice NS. Trabeculectomy combined with beta irradiation for congenital glaucoma. Br J Ophthalmology. 1991;75(10):584–590. doi: 10.1136/bjo.75.10.584
  52. Arestov DO. Surgical aspects of ultrasound trabeculectomy in the treatment of congenital glaucoma in children. Russian Pediatric ophthalmology. 2014;(1):5–11. (in Russ.) EDN: RWULJZ
  53. Fu GL, Alexander JL, Saeedi OJ. Persistent corneal edema associated with subconjunctival 5-fluorouracil in an infant with primary congenital glaucoma. J Pediatric Ophthalmol Strabismus. 2016;22(53):54–57. doi: 10.3928/01913913-20161003-01
  54. Arestov DO, Khvatova AV. Comparative effectiveness of ultrasound and traditional trabeculectomy for congenital glaucoma in children. Russian Pediatric ophthalmology. 2014;9(3):3. (In Russ.) doi: 10.17816/rpoj37609
  55. Freedman SF, McCormick K, Cox TA. Mitomycin C-augumented trabeculectomy with postoperative wound modulation in . doi:
  56. Chen CW, Huang HT, Bair JS, Lee CC. Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. J Ocul Pharmacol. 1990;6(3):175–182. doi: 10.1089/jop.1990.6.175
  57. Azuara-Blanco A, Wilson RP, Spaeth GL, et al. Filtration procedures supplemented with mitomycin C in the management of childhood glaucoma. Br J Ophthalmol. 1999;83(2):151–156. doi: 10.1136/bjo.83.2.151
  58. Jayaram H, Scawn R, Pooley F, et al. Long-term outcome of trabeculectomy augmented with mitomycin C undertaken within the first two years of life. Ophthalmology. 2015;122(11):2216–2222. doi: 10.1016/j.ophtha.2015.07.028
  59. al-Hazmi A, Zwaan J, Awad A, et al. Effectiveness and complications of mitomycin C use during pediatric glaucoma surgery. Ophthalmology. 1998;105(10):1915–1920. doi: 10.1016/S0161-6420(98)91041-7
  60. Freedman SF, McCormick K, Cox TA. Mitomycin C-augumented trabeculectomy with postoperative wound modulation in pediatric glaucoma. J AAPOS. 1999;3(2):117–124. doi: 10.1016/s1091-8531(99)70082-0
  61. Mandal AK, Prasad K, Naduvilath TJ. Surgical results and complications of mitomycin C-augmented trabeculectomy in refractory developmental glaucoma. Ophthalmic Surg Lasers. 1999;30(6):473–480.
  62. Dave P, Senthil S, Choudhari N, Sekhar GC. Outcomes of Ahmed valve implant following a failed initial trabeculotomy and trabeculectomy in refractory primary congenital glaucoma. Middle East Afr J Ophthalmol. 2015;22(1):64–68. doi: 10.4103/0974-9233.148351
  63. Arestova NN, Panova AYu, Pleskova AV, Sorokin AA. On the question of the reasons for the ineffectiveness of sinustrabeculectomy in children with congenital glaucoma. Russian pediatric ophthalmology. 2022;17(1):19–24 (In Russ.) doi: 10.21516/2072-0076-2022-15-3-26-33
  64. Lerner SF. Small incision trabeculectomy avoiding Tenon’s capsule. A new procedure for glaucoma surgery. Ophthalmology. 1997;104(8):1237–1241. doi: 10.1016/s0161-6420(97)30152-3
  65. Khvatova AV, Zakharova GP, Arestov DO. Features of the morphology of scar tissue of incompetent filtration cushions in congenital glaucoma in children. In: Proceedings of the I International Scientific and Practical Conference “Proliferative Syndrome in Ophthalmology”. Moscow, 2000 Nov 29–30. Moscow; 2000. P. 9–10. (In Russ.)
  66. Patent RUS №2199295/ 27.02.2003. Byul. №6. Kodzov MB, Arestov DO. Method of surgical treatment of congenital glaucoma in children using combined ultrasound trabeculectomy. Available from: https://new.fips.ru/iiss/document.xhtml?faces-redirect=true&id=ed5955212ba7280611eb8bfaa2389ed1 (In Russ.) EDN: MRVXRF
  67. Patent RUS №2633342 C/ 11.10.2017. Byull. №29. Katargina LA, Arestova NN, Denisova EV, Egiyan NS, Ibeid BNA. A method of YAG laser re-fistulization for blocking an internal fistula after sinustrabeculectomy in children with postveal glaucoma. Available from: https://new.fips.ru/iiss/document.xhtml?faces-redirect=true&id=b280cf66b21821e11b531f4e5871953a (In. Russ.) EDN: MTXBAV
  68. Arestova NN. Results, indications and optimal timing of YAG laser reconstructive surgery of the anterior eye in children. Vestnik Ophthalmologii, 2009;125(3):38–45. (In Russ.) EDN: KVTWMZ

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».